tradingkey.logo

Envoy Medical Inc

COCH
0.471USD
-0.051-9.85%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
11.23MMarktkapitalisierung
VerlustKGV TTM

Envoy Medical Inc

0.471
-0.051-9.85%

mehr Informationen über Envoy Medical Inc Unternehmen

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Envoy Medical Inc Informationen

BörsenkürzelCOCH
Name des UnternehmensEnvoy Medical Inc
IPO-datumMar 02, 2021
CEOLucas (Brent T)
Anzahl der mitarbeiter42
WertpapierartOrdinary Share
GeschäftsjahresendeMar 02
Addresse4875 White Bear Parkway
StadtWHITE BEAR LAKE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55110
Telefon16513618000
Websitehttps://www.envoymedical.com/
BörsenkürzelCOCH
IPO-datumMar 02, 2021
CEOLucas (Brent T)

Führungskräfte von Envoy Medical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
237.17K
+2578.00%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
237.17K
+2578.00%
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Thu, Feb 5
Aktualisiert: Thu, Feb 5
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.21%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.81%
Andere
59.46%
Aktionäre
Aktionäre
Anteil
Taylor (Glen A)
35.75%
Atlas Merchant Capital LLC
1.93%
The Vanguard Group, Inc.
1.21%
Weiss Asset Management
0.84%
Lucas (Brent T)
0.81%
Andere
59.46%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
37.07%
Investment Advisor
2.67%
Private Equity
1.93%
Investment Advisor/Hedge Fund
1.27%
Hedge Fund
1.23%
Research Firm
0.06%
Andere
55.76%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
47
2.25M
9.80%
+81.14K
2025Q3
59
2.17M
17.45%
-288.93K
2025Q2
64
2.46M
24.39%
+3.06K
2025Q1
70
2.46M
24.73%
-2.82M
2024Q4
143
2.12M
158.30%
+927.59K
2024Q3
151
1.20M
185.14%
-129.06K
2024Q2
157
1.33M
194.46%
+97.08K
2024Q1
156
1.23M
199.37%
-37.85M
2023Q4
150
1.71M
201.29%
-1.36M
2023Q3
149
3.06M
201.92%
-985.94K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Taylor (Glen A)
10.29M
35.75%
--
--
Dec 18, 2025
Atlas Merchant Capital LLC
555.53K
1.93%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
339.11K
1.18%
-55.85K
-14.14%
Sep 30, 2025
Weiss Asset Management
242.64K
0.84%
-125.50K
-34.09%
Sep 30, 2025
Lucas (Brent T)
237.17K
0.82%
+2.58K
+1.10%
Dec 18, 2025
Focus Partners Wealth, LLC
212.66K
0.74%
--
--
Sep 30, 2025
Arcus Capital Partners, LLC
152.87K
0.53%
-34.70K
-18.50%
Sep 30, 2025
Meteora Capital LLC
108.51K
0.38%
+81.14K
+296.46%
Oct 17, 2025
Kantor (Susan J.)
77.89K
0.27%
--
--
Dec 18, 2025
CIBC Private Wealth Management
77.89K
0.27%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI